These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
30. Value of urinary cytology in the diagnosis and management of urinary tract malignancies. Gaston KE; Pruthi RS Urology; 2004 Jun; 63(6):1009-16. PubMed ID: 15183936 [No Abstract] [Full Text] [Related]
31. [The diagnosis and treatment for carcinoma in situ of the bilateral upper urinary tracts after total cystectomy and ileal conduit by intentionally inducing hydronephrosis]. Saito J; Kato T; Kakuta Y; Tanaka M; Yazawa K; Hosomi M; Ito K Hinyokika Kiyo; 2006 Jul; 52(7):573-5. PubMed ID: 16910594 [TBL] [Abstract][Full Text] [Related]
32. Fluorescence in situ hybridization: a multitarget approach in diagnosis and management of urothelial cancer. Arentsen HC; de la Rosette JJ; de Reijke TM; Langbein S Expert Rev Mol Diagn; 2007 Jan; 7(1):11-9. PubMed ID: 17187480 [TBL] [Abstract][Full Text] [Related]
33. [Value of urinary cytology in urological diagnosis. Report after ten years (author's transl)]. Jocham D; Göttinger H; Schmiedt E Urologe A; 1982 Mar; 21(2):79-83. PubMed ID: 7200668 [TBL] [Abstract][Full Text] [Related]
34. The occult urothelial cancer. Ragonese M; Racioppi M; D'Agostino D; Di Gianfrancesco L; Lenci N; Bientinesi R; Palermo G; Sacco E; Pinto F; Bassi PF Urologia; 2016 May; 83(2):55-60. PubMed ID: 26481721 [TBL] [Abstract][Full Text] [Related]
35. Combined morphologic and fluorescence in situ hybridization analysis of voided urine samples for the detection and follow-up of bladder cancer in patients with benign urine cytology. Daniely M; Rona R; Kaplan T; Olsfanger S; Elboim L; Freiberger A; Lew S; Leibovitch I Cancer; 2007 Dec; 111(6):517-24. PubMed ID: 17963263 [TBL] [Abstract][Full Text] [Related]
39. Improved risk stratification for patients with high-grade urothelial carcinoma following application of the Paris System for Reporting Urinary Cytology. Cowan ML; Rosenthal DL; VandenBussche CJ Cancer Cytopathol; 2017 Jun; 125(6):427-434. PubMed ID: 28272842 [TBL] [Abstract][Full Text] [Related]
40. Evaluation of patients with carcinoma in situ of the bladder. Koss LG Pathol Annu; 1982; 17 Pt 2():353-9. PubMed ID: 7182757 [No Abstract] [Full Text] [Related] [Previous] [Next] [New Search]